EUVIMED · CrossrefZeitschrift
ASPET Discovery
ISSN 3050-5674 · Elsevier BV
Neueste Artikel
In silico design of 3-methyl-3H-naphtho[1,2,3-de]quinoline-2,7-dione inhibitors against tuberculosis via docking and dynamics simulation techniques and pharmacokinetic evaluation
Flavan-3-gallate catechins in green tea (Camellia sinensis) reduce amiodarone solubility and dissolution in fasted state simulated intestinal fluid
Methyl eugenol as a multitarget-directed ligand for Alzheimer disease: A promising lead for drug design
Differential effects of acute versus repeated chemogenetic activation of the mesocorticolimbic dopamine pathway on cocaine choice in male and female TH:Cre rats
Association of glyoxalase I inhibition by angiotensin II receptor blockers with adverse events in diabetic patients
Endoxifen-glucuronide and 4-hydroxy-tamoxifen glucuronide are substrates of OATP1A2
Standardized Tribulus terrestris L. extract ameliorates neuropathic pain through anti-inflammatory and GABAergic mechanism—in vitro and in vivo studies
Advances in computer-aided drug design: From molecular docking to artificial intelligence-driven therapeutic discovery
Insights and perspectives into the etiology of TKI-induced cardiotoxicity
PP2A regulation in acute myeloid leukemia: Mechanisms, stem cell biology, and therapeutic implication
Neo-protein-protein interaction rewires oncogenic BRAF mutations to the p53 tumor-suppressor machinery
Behavioral pharmacology in biopharma drug discovery: With gratitude to its founders
Emerging concepts on one-carbon metabolism as a unique and actionable vulnerability in cancer
A soliloquy on synergy
The α5 subunit-containing GABAA receptor positive allosteric modulator MP-III-022 both prevents and reverses perioperative neurocognitive disorder in aged mice
Mechanistic insights into toll/interleukin-1 receptor domain-containing adaptor protein (TIRAP) in cancer
Fatty acid–binding proteins as emerging immunometabolic regulators and therapeutic targets in multiple sclerosis and neurodegeneration: Promise, mechanistic gaps, and translational hurdles
Liver imaging to investigate hepatocyte transporter–mediated drug-drug interactions
Multimetric synergy analysis of WEE1 inhibitor adavosertib with DNA-damaging drugs identifies candidate therapeutic windows in a triple-negative breast cancer cell line model
Virtual screening and molecular mechanism of environmental persistence and reproductive toxicity of atrazine derivatives
From biochemical time–resolved fluorescence resonance energy transfer assay to live cell nanobio-luminescence resonance energy transfer assay: A case study with the bromodomain-containing protein 4 protein
Phenotypic assays, high-throughput microscopy and high-content analysis in drug screening
Integrative strategies in breast cancer therapy: Conventional approaches, emerging advances, and future challenges
ASPET Discovery launches!
NEK2 inhibition alleviates lipopolysaccharide-induced endothelial injury
Evaluation of molecular glue–induced neomorphic protein-protein interaction with a cell lysate–based time-resolved fluorescence resonance energy transfer assay
In vitro and in silico pharmacological profiling of 3-(4,5-diaryl-1H-imidazol-2-yl)quinoline-2-amine hybrids
Strain-dependent neuronal disposition and toxicity of paclitaxel in mice
Levetiracetam: An antiseizure drug with unique neuroprotective properties
Ecofriendly silver nanoparticle synthesis, physicochemical characterization from Datura stramonium, and its biological applications in Parkinson Drosophila model
EUVIMED